Hep Winter 2016 - Special Issue
Hep Winter 2016 - Special Issue
In every issue of HEP, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
Feature
Through the Uprights: Former NFL star Rolf Benirsche kicks hepatitis C
Former NFL star turned activist Rolf Benirschke kicks hepatitis C.
From The Editor
Alive and Kicking
Rolf Benirschke became a hepatitis C virus (HCV) treatment advocate after he tested HCV positive while applying for life insurance in 1998.
News
Beware Herbal and Dietary Supplements
Herbal and dietary supplements are now a major risk factor for chemical-induced liver damage across the United States.
Do Your Meds Cost Too Much?:
#FairDrugPricesNow campaign calls for more transparency among drug companies.
Participate in a Virtual Hepatitis C Study
New app allows people living with HCV to take part in a research study aimed at tracking antiviral medication effects.
“Liver in a Box” Machine for Transplants
First hospital in the United States performs a liver transplant using a new high-tech machine are calling the “liver in a box.”
Treatment News
Eight Weeks of Harvoni
German study shows high hepatitis C virus cure rates after eight weeks of Harvoni (ledipasvir/sofosbuvir) treatment.
Upcoming Short-Course Treatment
An experimental hepatitis C virus (HCV) treatment regimen given for just six or eight weeks has shown promise in a mid-stage trial.
Treat All, Save Money
Treating all those with hepatitis C virus (HCV) who are on Medicaid would save money and improve the health and longevity of the population.
Curing Hep C After a Transplant
Hepatitis C virus (HCV) cure rates among those who have received a liver transplant are very good.
